Screening for Intrapartum Fetal Compromise Using Placental Biomarkers

Prediction of Placenta Accreta Outcome in Pregnant Woman With Placenta Previa Using (hcg_h ) as Abiomarkers

NCT06761885 ·Status: NOT_YET_RECRUITING

Study of Placental Function in Healthy and Pathological Pregnancies

NCT02321007 ·Status: RECRUITING

Patients Pregnant Women With or Without Primary Antiphospholipid Antibody Syndrome

NCT05786235 ·Status: RECRUITING

Biomarkers and Preeclampsia Outcomes

NCT03801447 ·Status: COMPLETED

Maternal and Fetal Metabolic Changes

NCT06288126 ·Status: COMPLETED

Non-invasive Placental Chromosome Exploration of Intrauterine Growth Restriction

NCT05023161 ·Status: RECRUITING

sFlt-1/PlGF Ratio: Impact on the Management of Patients With Suspected Pre-eclampsia

NCT05228002 ·Status: COMPLETED ·Phase: NA

Screening for Preeclampsia With Various Markers in Low-risk Pregnancy Populations

NCT01649128 ·Status: COMPLETED

Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women

NCT03767803 ·Status: UNKNOWN

Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester

NCT02990767 ·Status: UNKNOWN

Biomarkers in Obstetrical Complications

NCT03480139 ·Status: COMPLETED

Prediction of Preeclampsia by Comprehensive Markers.

NCT03665623 ·Status: COMPLETED

Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .

NCT03638024 ·Status: UNKNOWN

Fetus Programming and Long Active Outcomes, Interaction Between Mother, Placenta and Fetus in Perinatal and Methabolic Disbalansces-focusing Diabetic Pregnancies

NCT07337759 ·Status: COMPLETED

Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker

NCT06873737 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Evaluation of Fetoplacental Oxygenation With Functional MRI in Pregnant Women

NCT02238301 ·Status: COMPLETED ·Phase: NA

Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers

NCT02808494 ·Status: COMPLETED

sFlt-1:PlGF Ratio in Gestational Diabetes: PREDICTION (PREeclampsia in DIabetiC gestaTION) Study

NCT04877119 ·Status: UNKNOWN

Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia

NCT03903393 ·Status: UNKNOWN

Parvovirus B19 Infection in Pregnancy: Clinical Manifestations and Fetus/Newborn Outcome

NCT07338279 ·Status: RECRUITING

Development of a Predictive Model of Fetal PH At Birth from Novel Variables Derived from Cardiotocographic Tracing

NCT06720363 ·Status: RECRUITING

Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia

NCT06214702 ·Status: COMPLETED

Characteristics, Complications and Perinatal Outcomes in Placenta Previa Women

NCT03774667 ·Status: UNKNOWN

Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China

NCT01804751 ·Status: UNKNOWN

Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia

NCT02286284 ·Status: TERMINATED ·Phase: PHASE2